<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03138577</url>
  </required_header>
  <id_info>
    <org_study_id>1609017547</org_study_id>
    <nct_id>NCT03138577</nct_id>
  </id_info>
  <brief_title>Dose-Response Relationships for Hemidiaphragmatic Paresis Following Ultrasound-Guided Supraclavicular Block</brief_title>
  <official_title>Dose-Response Relationships for Hemidiaphragmatic Paresis Following Ultrasound-Guided Supraclavicular Brachial Plexus Blockade</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Weill Medical College of Cornell University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Weill Medical College of Cornell University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This clinical trial is for subjects undergoing right upper extremity surgery. The aim of the
      study is to investigate the dose-response relationship between local anesthetic volume and
      ipsilateral hemidiaphragmatic paresis (HDP) in patients getting ultrasound-guided
      supraclavicular brachial plexus blocks in a blinded, prospective trial.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      With traditional landmark-based or nerve-stimulator techniques, the incidence of HDP
      following supraclavicular blocks is approximately 50-67%. Ultrasound-guided techniques are
      thought to enhance precision while reducing the volume of anesthetic used, but even then HDP
      incidence is nearly 60%. To date, no trials have studied the dose-response relationship
      between local anesthetic volume and degree of HDP.

      Patient Selection

      30 eligible patients undergoing right upper extremity surgery and eligible for
      supraclavicular blocks will be recruited at NewYork-Presbyterian/Weill Cornell Medical
      Center.

      Evaluation of HDP

      Baseline M-mode recordings of diaphragm function will be made by an anesthesiologist.
      Patients will perform &quot;voluntary sniff&quot; (VS) tests, or forceful nasal inhales, immediately
      preceding the brachial plexus blockade, and again at 15 minutes and 30 minutes after the
      block.

      Diaphragmatic excursion from baseline will be measured in centimeters; three measurements
      will be made and averaged. Hemidiaphragmatic paresis will be defined as greater than or equal
      to 60% reduction in diaphragmatic excursion, no movement, or paradoxical movement in the VS
      test.

      Evaluation of Pulmonary Function

      A bedside negative inspiratory force (NIF) meter will be used to measure negative inspiratory
      force prior to the block and 30 minutes after the block.

      Evaluation of Supraclavicular Block

      At the 15- and 30-minute marks, the investigators will assess sensory blockade and motor
      block in the axial, musculocutaneous, radial, median, and ulnar distributions. Both will be
      judged on 3-point scales. The investigators will also apply a 0-10 point verbal rating scale
      to assess dyspnea at 30 minutes. Oxygen saturation will be measured off of supplemental
      oxygen before the block and 30 minutes after the block.

      Following the assessments, patients will have surgery using brachial plexus blockade as the
      primary anesthetic.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 12, 2018</start_date>
  <completion_date type="Actual">July 30, 2019</completion_date>
  <primary_completion_date type="Actual">July 30, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>A modified &quot;3+3&quot; dose escalation design, modeled after Phase I dose-finding trials, was used to define the dose response curve for local anesthetic volume in the supraclavicular block and resulting hemidiaphragmatic paresis in patients undergoing right upper extremity surgery with supraclavicular block as the primary anesthetic. Possible dosing levels of 5, 10, 15, 20, 25, 30, 35 and 40 mL of local anesthetic were pre-specified with a cohort of three subjects per dose. Diaphragm function was determined by a blinded assessor with M-mode tracings of the right diaphragm before and after supraclavicular block. Secondary objectives included the assessment of respiratory function via negative inspiratory force, oxygen saturation and subjective dyspnea, as well as the extent of sensory and motor blockade.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>The physician reviewing the ultrasound images and determining the presence/absence of diaphragm paralysis is masked to treatment assignment.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Subjects With Hemidiaphragmatic Paresis at Various Volumes of Local Anesthetic 15 Minutes After Supraclavicular Block</measure>
    <time_frame>15 minutes</time_frame>
    <description>Diaphragm motion was recorded during voluntary sniffing fifteen minutes after supraclavicular block with the specified volume of local anesthetic. Blinded investigators reviewed the scans and determined whether the scans were indicative of hemidiaphragmatic paresis (HDP) or not (No HDP). This data was fit to a dose response curve.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Subjects With Hemidiaphragmatic Paresis at Various Volumes of Local Anesthetic 30 Minutes After Supraclavicular Block</measure>
    <time_frame>30 minutes</time_frame>
    <description>Diaphragm motion was recorded during voluntary sniffing 30 minutes after supraclavicular block with the specified volume of local anesthetic. Blinded investigators reviewed the scans and determined whether the scans were indicative of hemidiaphragmatic paresis (HDP) or not (No HDP). This data was fit to a dose response curve.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Negative Inspiratory Force (NIF) at 30 Minutes</measure>
    <time_frame>30 minutes</time_frame>
    <description>The change of the absolute value of NIF from the baseline measurement to that at 30 minutes after the block</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dose Response Curve for Motor and Sensory Block 15 Minutes After Block</measure>
    <time_frame>15 minutes</time_frame>
    <description>As described in the protocol, each subject's block was assessed via motor and sensory exam at 15 minutes and given a score (0-20), with 20 being a perfect block and any score less than 10 indicating an ineffective block. A dose response curve was generated for block score with different volumes of local anesthetic administered.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dose Response Curve for Motor and Sensory Block Score 30 Minutes After Block</measure>
    <time_frame>30 minutes</time_frame>
    <description>As described in the protocol, each subject's block was assessed via motor and sensory exam at 30 minutes and given a score (0-20), with 20 being a perfect block and any score less than 10 indicating an ineffective block. A dose response curve was generated for block score with different volumes of local anesthetic administered.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Room Air Oxygen Saturation at 30 Minutes.</measure>
    <time_frame>30 minutes</time_frame>
    <description>The change in room air oxygen saturation from baseline to 30 minutes after the block was calculated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective Dyspnea 30 Minutes After Block</measure>
    <time_frame>30 minutes</time_frame>
    <description>30 minutes after the block, patients were asked to rate any symptoms of dyspnea on a scale of 0 (no trouble breathing) to 10 (extreme trouble breathing).</description>
  </secondary_outcome>
  <number_of_arms>7</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Surgery of Right Upper Extremity</condition>
  <arm_group>
    <arm_group_label>Dose Cohort 7</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>5 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine Ultrasound Imaging Bedside Negative Inspiratory Force Meter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dose Cohort 6</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>10 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine Ultrasound Imaging Bedside Negative Inspiratory Force Meter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dose Cohort 5</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>15 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine Ultrasound Imaging Bedside Negative Inspiratory Force Meter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dose Cohort 4</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>20 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine Ultrasound Imaging Bedside Negative Inspiratory Force Meter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dose Cohort 3</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Supraclavicular Block: 25 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine Ultrasound Imaging Bedside Negative Inspiratory Force Meter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dose Cohort 2</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>30 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine Ultrasound Imaging Bedside Negative Inspiratory Force Meter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dose Cohort 1</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>35 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine Ultrasound Imaging Bedside Negative Inspiratory Force Meter</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Ultrasound Imaging</intervention_name>
    <description>M-mode tracings of right diaphragm motion will be made and recorded by a skilled anesthesiologist. Patients will be examined in the supine position and scanned from a low intercostal or subcostal approach using the liver as an acoustic window. Patients will be asked to perform a &quot;voluntary sniff&quot; (VS) test, for which they will be asked to forcefully inhale through the nose in a sniffing position. The above measurement will be performed immediately preceding the brachial plexus blockade, and then at 15 minute and 30 minutes after block.</description>
    <arm_group_label>Dose Cohort 1</arm_group_label>
    <arm_group_label>Dose Cohort 2</arm_group_label>
    <arm_group_label>Dose Cohort 3</arm_group_label>
    <arm_group_label>Dose Cohort 4</arm_group_label>
    <arm_group_label>Dose Cohort 5</arm_group_label>
    <arm_group_label>Dose Cohort 6</arm_group_label>
    <arm_group_label>Dose Cohort 7</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Supraclavicular Block</intervention_name>
    <description>The patient will be positioned supine with the head turned to the contralateral side. The ultrasound will be placed in the supraclavicular fossa, and the skin and subcutaneous tissues will be infiltrated lateral to the probe with 2% lidocaine. The anesthesiologist can redirect the needle and perform additional injections for complete coverage of the brachial plexus. The local anesthetic will be a 2:1 mix of 1.5% mepivacaine and 0.5% bupivacaine.</description>
    <arm_group_label>Dose Cohort 1</arm_group_label>
    <arm_group_label>Dose Cohort 2</arm_group_label>
    <arm_group_label>Dose Cohort 3</arm_group_label>
    <arm_group_label>Dose Cohort 4</arm_group_label>
    <arm_group_label>Dose Cohort 5</arm_group_label>
    <arm_group_label>Dose Cohort 6</arm_group_label>
    <arm_group_label>Dose Cohort 7</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Bedside Negative Inspiratory Force Meter</intervention_name>
    <description>A bedside negative inspiratory force (NIF) meter will be used to measure negative inspiratory force prior to the block and 30 minutes after the block.</description>
    <arm_group_label>Dose Cohort 1</arm_group_label>
    <arm_group_label>Dose Cohort 2</arm_group_label>
    <arm_group_label>Dose Cohort 3</arm_group_label>
    <arm_group_label>Dose Cohort 4</arm_group_label>
    <arm_group_label>Dose Cohort 5</arm_group_label>
    <arm_group_label>Dose Cohort 6</arm_group_label>
    <arm_group_label>Dose Cohort 7</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Undergoing right upper extremity surgery with supraclavicular block as the primary
             anesthetic

          -  Age greater than or equal to 18 years of age

          -  American Society of Anesthesiologists (ASA) physical status 1 to 3

          -  Able to give informed consent

        Exclusion Criteria:

          -  Patient refusal for supraclavicular block

          -  Inability to give informed consent

          -  Allergy to local anesthetics

          -  Hemidiaphragmatic dysfunction, suspected or known pulmonary disease

          -  Neuromuscular disease

          -  Obstructive or restrictive pulmonary disease

          -  Medical or anatomic contraindication to supraclavicular blockade as judged by
             clinician

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>105 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tiffany Tedore, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>WCMC, NYP</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Weill Cornell Medical College</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Renes SH, Spoormans HH, Gielen MJ, Rettig HC, van Geffen GJ. Hemidiaphragmatic paresis can be avoided in ultrasound-guided supraclavicular brachial plexus block. Reg Anesth Pain Med. 2009 Nov-Dec;34(6):595-9.</citation>
    <PMID>19916254</PMID>
  </reference>
  <reference>
    <citation>Petrar SD, Seltenrich ME, Head SJ, Schwarz SK. Hemidiaphragmatic paralysis following ultrasound-guided supraclavicular versus infraclavicular brachial plexus blockade: a randomized clinical trial. Reg Anesth Pain Med. 2015 Mar-Apr;40(2):133-8. doi: 10.1097/AAP.0000000000000215.</citation>
    <PMID>25650633</PMID>
  </reference>
  <reference>
    <citation>Kant A, Gupta PK, Zohar S, Chevret S, Hopkins PM. Application of the continual reassessment method to dose-finding studies in regional anesthesia: an estimate of the ED95 dose for 0.5% bupivacaine for ultrasound-guided supraclavicular block. Anesthesiology. 2013 Jul;119(1):29-35. doi: 10.1097/ALN.0b013e31829764cf. Erratum in: Anesthesiology. 2015 Sep;123(3):740.</citation>
    <PMID>23648519</PMID>
  </reference>
  <reference>
    <citation>Boussuges A, Gole Y, Blanc P. Diaphragmatic motion studied by m-mode ultrasonography: methods, reproducibility, and normal values. Chest. 2009 Feb;135(2):391-400. doi: 10.1378/chest.08-1541. Epub 2008 Nov 18.</citation>
    <PMID>19017880</PMID>
  </reference>
  <reference>
    <citation>Mier-Jedrzejowicz A, Brophy C, Moxham J, Green M. Assessment of diaphragm weakness. Am Rev Respir Dis. 1988 Apr;137(4):877-83.</citation>
    <PMID>3354995</PMID>
  </reference>
  <reference>
    <citation>Soares LG, Brull R, Lai J, Chan VW. Eight ball, corner pocket: the optimal needle position for ultrasound-guided supraclavicular block. Reg Anesth Pain Med. 2007 Jan-Feb;32(1):94-5.</citation>
    <PMID>17196502</PMID>
  </reference>
  <reference>
    <citation>Tedore TR, YaDeau JT, Maalouf DB, Weiland AJ, Tong-Ngork S, Wukovits B, Paroli L, Urban MK, Zayas VM, Wu A, Gordon MA. Comparison of the transarterial axillary block and the ultrasound-guided infraclavicular block for upper extremity surgery: a prospective randomized trial. Reg Anesth Pain Med. 2009 Jul-Aug;34(4):361-5. doi: 10.1097/AAP.0b013e3181ac9e2d.</citation>
    <PMID>19574870</PMID>
  </reference>
  <reference>
    <citation>O'Quigley J, Pepe M, Fisher L. Continual reassessment method: a practical design for phase 1 clinical trials in cancer. Biometrics. 1990 Mar;46(1):33-48.</citation>
    <PMID>2350571</PMID>
  </reference>
  <reference>
    <citation>Garrett-Mayer E. The continual reassessment method for dose-finding studies: a tutorial. Clin Trials. 2006;3(1):57-71.</citation>
    <PMID>16539090</PMID>
  </reference>
  <reference>
    <citation>Neal JM. Ultrasound-Guided Regional Anesthesia and Patient Safety: Update of an Evidence-Based Analysis. Reg Anesth Pain Med. 2016 Mar-Apr;41(2):195-204. doi: 10.1097/AAP.0000000000000295.</citation>
    <PMID>26695877</PMID>
  </reference>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 24, 2017</study_first_submitted>
  <study_first_submitted_qc>May 1, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 3, 2017</study_first_posted>
  <results_first_submitted>April 29, 2020</results_first_submitted>
  <results_first_submitted_qc>April 29, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">May 13, 2020</results_first_posted>
  <last_update_submitted>April 29, 2020</last_update_submitted>
  <last_update_submitted_qc>April 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paresis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>December 5, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/77/NCT03138577/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Study subjects were recruited from August 2018 to July 2019. Fifty-nine subjects were assessed for eligibility. Fourteen subjects were excluded or refused to participate, and 21 were eligible but not approached due to the anticipation of insufficient time to complete assessments. Twenty-four patients consented to enrollment.</recruitment_details>
      <pre_assignment_details>3 of the 24 enrolled patients were excluded due to baseline abnormal diaphragm motion or inability to visualize the diaphragm on baseline ultrasound scan.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Dose Cohort 7</title>
          <description>Supraclavicular block performed with 5 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
        </group>
        <group group_id="P2">
          <title>Dose Cohort 6</title>
          <description>Supraclavicular block performed with 10 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
        </group>
        <group group_id="P3">
          <title>Dose Cohort 5</title>
          <description>Supraclavicular block performed with 15 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
        </group>
        <group group_id="P4">
          <title>Dose Cohort 4</title>
          <description>Supraclavicular block performed with 20 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
        </group>
        <group group_id="P5">
          <title>Dose Cohort 3</title>
          <description>Supraclavicular block performed with 25 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
        </group>
        <group group_id="P6">
          <title>Dose Cohort 2</title>
          <description>Supraclavicular block performed with 30 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
        </group>
        <group group_id="P7">
          <title>Dose Cohort 1</title>
          <description>Supraclavicular block performed with 35 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="3"/>
                <participants group_id="P5" count="3"/>
                <participants group_id="P6" count="3"/>
                <participants group_id="P7" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="3"/>
                <participants group_id="P5" count="3"/>
                <participants group_id="P6" count="3"/>
                <participants group_id="P7" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>5 mL</title>
          <description>5 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
        </group>
        <group group_id="B2">
          <title>10 mL</title>
          <description>10 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
        </group>
        <group group_id="B3">
          <title>15 mL</title>
          <description>15 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
        </group>
        <group group_id="B4">
          <title>20 mL</title>
          <description>20 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
        </group>
        <group group_id="B5">
          <title>25 mL</title>
          <description>25 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
        </group>
        <group group_id="B6">
          <title>30 mL</title>
          <description>30 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
        </group>
        <group group_id="B7">
          <title>35 mL</title>
          <description>35 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
        </group>
        <group group_id="B8">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="3"/>
            <count group_id="B2" value="3"/>
            <count group_id="B3" value="3"/>
            <count group_id="B4" value="3"/>
            <count group_id="B5" value="3"/>
            <count group_id="B6" value="3"/>
            <count group_id="B7" value="3"/>
            <count group_id="B8" value="21"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="3"/>
                    <count group_id="B2" value="3"/>
                    <count group_id="B3" value="3"/>
                    <count group_id="B4" value="3"/>
                    <count group_id="B5" value="3"/>
                    <count group_id="B6" value="3"/>
                    <count group_id="B7" value="3"/>
                    <count group_id="B8" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="2"/>
                    <measurement group_id="B7" value="3"/>
                    <measurement group_id="B8" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="2"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="3"/>
                    <count group_id="B2" value="3"/>
                    <count group_id="B3" value="3"/>
                    <count group_id="B4" value="3"/>
                    <count group_id="B5" value="3"/>
                    <count group_id="B6" value="3"/>
                    <count group_id="B7" value="3"/>
                    <count group_id="B8" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="3"/>
                    <measurement group_id="B6" value="3"/>
                    <measurement group_id="B7" value="2"/>
                    <measurement group_id="B8" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                    <count group_id="B4" value="0"/>
                    <count group_id="B5" value="0"/>
                    <count group_id="B6" value="0"/>
                    <count group_id="B7" value="0"/>
                    <count group_id="B8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="3"/>
                    <count group_id="B2" value="3"/>
                    <count group_id="B3" value="3"/>
                    <count group_id="B4" value="3"/>
                    <count group_id="B5" value="3"/>
                    <count group_id="B6" value="3"/>
                    <count group_id="B7" value="3"/>
                    <count group_id="B8" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="3"/>
                    <measurement group_id="B6" value="3"/>
                    <measurement group_id="B7" value="3"/>
                    <measurement group_id="B8" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>ASA Classification</title>
          <description>American Society of Anesthesiologists (ASA) Classification:
I: Normal, healthy patient II: Patient with mild systemic disease III: Patient with severe systemic disease</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="3"/>
                    <count group_id="B2" value="3"/>
                    <count group_id="B3" value="3"/>
                    <count group_id="B4" value="3"/>
                    <count group_id="B5" value="3"/>
                    <count group_id="B6" value="3"/>
                    <count group_id="B7" value="3"/>
                    <count group_id="B8" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>ASA Class I</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>ASA Class II</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="3"/>
                    <measurement group_id="B6" value="2"/>
                    <measurement group_id="B7" value="2"/>
                    <measurement group_id="B8" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>ASA Class III</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Upper Extremity Surgery Location</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="3"/>
                    <count group_id="B2" value="3"/>
                    <count group_id="B3" value="3"/>
                    <count group_id="B4" value="3"/>
                    <count group_id="B5" value="3"/>
                    <count group_id="B6" value="3"/>
                    <count group_id="B7" value="3"/>
                    <count group_id="B8" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Proximal to elbow</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="2"/>
                    <measurement group_id="B8" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Mid arm (at elbow)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="2"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Distal to elbow</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Subjects With Hemidiaphragmatic Paresis at Various Volumes of Local Anesthetic 15 Minutes After Supraclavicular Block</title>
        <description>Diaphragm motion was recorded during voluntary sniffing fifteen minutes after supraclavicular block with the specified volume of local anesthetic. Blinded investigators reviewed the scans and determined whether the scans were indicative of hemidiaphragmatic paresis (HDP) or not (No HDP). This data was fit to a dose response curve.</description>
        <time_frame>15 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dose Cohort 7 (5 mL)</title>
            <description>Supraclavicular block performed with 5 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
          </group>
          <group group_id="O2">
            <title>Dose Cohort 6 (10 mL)</title>
            <description>Supraclavicular block performed with 10 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
          </group>
          <group group_id="O3">
            <title>Dose Cohort 5 (15 mL)</title>
            <description>Supraclavicular block performed with 15 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
          </group>
          <group group_id="O4">
            <title>Dose Cohort 4 (20 mL)</title>
            <description>Supraclavicular block performed with 20 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
          </group>
          <group group_id="O5">
            <title>Dose Cohort 3 (25 mL)</title>
            <description>Supraclavicular block performed with 25 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
          </group>
          <group group_id="O6">
            <title>Dose Cohort 2 (30 mL)</title>
            <description>Supraclavicular block performed with 30 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
          </group>
          <group group_id="O7">
            <title>Dose Cohort 1 (35 mL)</title>
            <description>Supraclavicular block performed with 35 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With Hemidiaphragmatic Paresis at Various Volumes of Local Anesthetic 15 Minutes After Supraclavicular Block</title>
          <description>Diaphragm motion was recorded during voluntary sniffing fifteen minutes after supraclavicular block with the specified volume of local anesthetic. Blinded investigators reviewed the scans and determined whether the scans were indicative of hemidiaphragmatic paresis (HDP) or not (No HDP). This data was fit to a dose response curve.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="3"/>
                <count group_id="O7" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>HDP</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No HDP</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
              <group_id>O5</group_id>
              <group_id>O6</group_id>
              <group_id>O7</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <other_analysis_desc>Counts and percentages of cases with paralysis were calculated separately for each volume of local anesthetic.</other_analysis_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Subjects With Hemidiaphragmatic Paresis at Various Volumes of Local Anesthetic 30 Minutes After Supraclavicular Block</title>
        <description>Diaphragm motion was recorded during voluntary sniffing 30 minutes after supraclavicular block with the specified volume of local anesthetic. Blinded investigators reviewed the scans and determined whether the scans were indicative of hemidiaphragmatic paresis (HDP) or not (No HDP). This data was fit to a dose response curve.</description>
        <time_frame>30 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dose Cohort 7 (5 mL)</title>
            <description>Supraclavicular block performed with 5 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
          </group>
          <group group_id="O2">
            <title>Dose Cohort 6 (10 mL)</title>
            <description>Supraclavicular block performed with 10 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
          </group>
          <group group_id="O3">
            <title>Dose Cohort 5 (15 mL)</title>
            <description>Supraclavicular block performed with 15 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
          </group>
          <group group_id="O4">
            <title>Dose Cohort 4 (20 mL)</title>
            <description>Supraclavicular block performed with 20 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
          </group>
          <group group_id="O5">
            <title>Dose Cohort 3 (25 mL)</title>
            <description>Supraclavicular block performed with 25 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
          </group>
          <group group_id="O6">
            <title>Dose Cohort 2 (30 mL)</title>
            <description>Supraclavicular block performed with 30 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
          </group>
          <group group_id="O7">
            <title>Dose Cohort 1 (35 mL)</title>
            <description>Supraclavicular block performed with 35 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With Hemidiaphragmatic Paresis at Various Volumes of Local Anesthetic 30 Minutes After Supraclavicular Block</title>
          <description>Diaphragm motion was recorded during voluntary sniffing 30 minutes after supraclavicular block with the specified volume of local anesthetic. Blinded investigators reviewed the scans and determined whether the scans were indicative of hemidiaphragmatic paresis (HDP) or not (No HDP). This data was fit to a dose response curve.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="3"/>
                <count group_id="O7" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>HDP</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No HDP</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
              <group_id>O5</group_id>
              <group_id>O6</group_id>
              <group_id>O7</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <other_analysis_desc>Counts and percentages of cases with paralysis were calculated separately for each volume of local anesthetic.</other_analysis_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Negative Inspiratory Force (NIF) at 30 Minutes</title>
        <description>The change of the absolute value of NIF from the baseline measurement to that at 30 minutes after the block</description>
        <time_frame>30 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Subjects With HDP</title>
            <description>All subjects, regardless of local anesthetic dose, that demonstrated HDP 30 minutes after block placement.</description>
          </group>
          <group group_id="O2">
            <title>Subjects Without HDP</title>
            <description>All subjects, regardless of local anesthetic dose, that did not demonstrate HDP 30 minutes after block placement.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Negative Inspiratory Force (NIF) at 30 Minutes</title>
          <description>The change of the absolute value of NIF from the baseline measurement to that at 30 minutes after the block</description>
          <units>cm H2O</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-7.5" lower_limit="-22.0" upper_limit="0"/>
                    <measurement group_id="O2" value="0" lower_limit="-10" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.01</p_value>
            <method>Sign test</method>
            <param_type>Median Difference (Final Values)</param_type>
            <param_value>7.5</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>1.00</p_value>
            <method>Sign test</method>
            <param_type>Median Difference (Final Values)</param_type>
            <param_value>0</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Dose Response Curve for Motor and Sensory Block 15 Minutes After Block</title>
        <description>As described in the protocol, each subject's block was assessed via motor and sensory exam at 15 minutes and given a score (0-20), with 20 being a perfect block and any score less than 10 indicating an ineffective block. A dose response curve was generated for block score with different volumes of local anesthetic administered.</description>
        <time_frame>15 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dose Cohort 7 (5 mL)</title>
            <description>Supraclavicular block performed with 5 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
          </group>
          <group group_id="O2">
            <title>Dose Cohort 6 (10 mL)</title>
            <description>Supraclavicular block performed with 10 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
          </group>
          <group group_id="O3">
            <title>Dose Cohort 5 (15 mL)</title>
            <description>Supraclavicular block performed with 15 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
          </group>
          <group group_id="O4">
            <title>Dose Cohort 4 (20 mL)</title>
            <description>Supraclavicular block performed with 20 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
          </group>
          <group group_id="O5">
            <title>Dose Cohort 3 (25 mL)</title>
            <description>Supraclavicular block performed with 25 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
          </group>
          <group group_id="O6">
            <title>Dose Cohort 2 (30 mL)</title>
            <description>Supraclavicular block performed with 30 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
          </group>
          <group group_id="O7">
            <title>Dose Cohort 1 (35 mL)</title>
            <description>Supraclavicular block performed with 35 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
          </group>
        </group_list>
        <measure>
          <title>Dose Response Curve for Motor and Sensory Block 15 Minutes After Block</title>
          <description>As described in the protocol, each subject's block was assessed via motor and sensory exam at 15 minutes and given a score (0-20), with 20 being a perfect block and any score less than 10 indicating an ineffective block. A dose response curve was generated for block score with different volumes of local anesthetic administered.</description>
          <units>score on a scale</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="3"/>
                <count group_id="O7" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Subject 1/3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="20"/>
                    <measurement group_id="O6" value="15"/>
                    <measurement group_id="O7" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Subject 2/3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="19"/>
                    <measurement group_id="O6" value="15"/>
                    <measurement group_id="O7" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Subject 3/3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="18"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="16"/>
                    <measurement group_id="O7" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
              <group_id>O5</group_id>
              <group_id>O6</group_id>
              <group_id>O7</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <other_analysis_desc>Dose response data was fit with a non-parametric smoothing technique for locally weighted regression (lowess) to produce a dose response curve.</other_analysis_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Dose Response Curve for Motor and Sensory Block Score 30 Minutes After Block</title>
        <description>As described in the protocol, each subject's block was assessed via motor and sensory exam at 30 minutes and given a score (0-20), with 20 being a perfect block and any score less than 10 indicating an ineffective block. A dose response curve was generated for block score with different volumes of local anesthetic administered.</description>
        <time_frame>30 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dose Cohort 7 (5 mL)</title>
            <description>Supraclavicular block performed with 5 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
          </group>
          <group group_id="O2">
            <title>Dose Cohort 6 (10 mL)</title>
            <description>Supraclavicular block performed with 10 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
          </group>
          <group group_id="O3">
            <title>Dose Cohort 5 (15 mL)</title>
            <description>Supraclavicular block performed with 15 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
          </group>
          <group group_id="O4">
            <title>Dose Cohort 4 (20 mL)</title>
            <description>Supraclavicular block performed with 20 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
          </group>
          <group group_id="O5">
            <title>Dose Cohort 3 (25 mL)</title>
            <description>Supraclavicular block performed with 25 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
          </group>
          <group group_id="O6">
            <title>Dose Cohort 2 (30 mL)</title>
            <description>Supraclavicular block performed with 30 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
          </group>
          <group group_id="O7">
            <title>Dose Cohort 1 (35 mL)</title>
            <description>Supraclavicular block performed with 35 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
          </group>
        </group_list>
        <measure>
          <title>Dose Response Curve for Motor and Sensory Block Score 30 Minutes After Block</title>
          <description>As described in the protocol, each subject's block was assessed via motor and sensory exam at 30 minutes and given a score (0-20), with 20 being a perfect block and any score less than 10 indicating an ineffective block. A dose response curve was generated for block score with different volumes of local anesthetic administered.</description>
          <units>score on a scale</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="3"/>
                <count group_id="O7" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Subject 1 of 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="20"/>
                    <measurement group_id="O5" value="20"/>
                    <measurement group_id="O6" value="14"/>
                    <measurement group_id="O7" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Subject 2 of 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="10"/>
                    <measurement group_id="O5" value="20"/>
                    <measurement group_id="O6" value="16"/>
                    <measurement group_id="O7" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Subject 3 of 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="18"/>
                    <measurement group_id="O4" value="16"/>
                    <measurement group_id="O5" value="16"/>
                    <measurement group_id="O6" value="16"/>
                    <measurement group_id="O7" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
              <group_id>O5</group_id>
              <group_id>O6</group_id>
              <group_id>O7</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <other_analysis_desc>Dose response data was fit with a non-parametric smoothing technique for locally weighted regression (lowess) to produce a dose response curve.</other_analysis_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Room Air Oxygen Saturation at 30 Minutes.</title>
        <description>The change in room air oxygen saturation from baseline to 30 minutes after the block was calculated.</description>
        <time_frame>30 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Subjects With HDP</title>
            <description>All subjects, regardless of local anesthetic dose, that demonstrated HDP 30 minutes after block placement.</description>
          </group>
          <group group_id="O2">
            <title>Subjects Without HDP</title>
            <description>All subjects, regardless of local anesthetic dose, that did not demonstrate HDP 30 minutes after block placement.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Room Air Oxygen Saturation at 30 Minutes.</title>
          <description>The change in room air oxygen saturation from baseline to 30 minutes after the block was calculated.</description>
          <units>percent</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1" lower_limit="-2" upper_limit="0"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.01</p_value>
            <method>Sign test</method>
            <param_type>Median Difference (Final Values)</param_type>
            <param_value>-1</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>1.00</p_value>
            <method>Sign test</method>
            <param_type>Median Difference (Final Values)</param_type>
            <param_value>0</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subjective Dyspnea 30 Minutes After Block</title>
        <description>30 minutes after the block, patients were asked to rate any symptoms of dyspnea on a scale of 0 (no trouble breathing) to 10 (extreme trouble breathing).</description>
        <time_frame>30 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Subjects With HDP</title>
            <description>All subjects, regardless of local anesthetic dose, that demonstrated HDP 30 minutes after block placement.</description>
          </group>
          <group group_id="O2">
            <title>Subjects Without HDP</title>
            <description>All subjects, regardless of local anesthetic dose, that did not demonstrate HDP 30 minutes after block placement.</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Dyspnea 30 Minutes After Block</title>
          <description>30 minutes after the block, patients were asked to rate any symptoms of dyspnea on a scale of 0 (no trouble breathing) to 10 (extreme trouble breathing).</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.08</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>48 hours</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Dose Cohort 7 (5 mL)</title>
          <description>Supraclavicular block performed with 5 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
        </group>
        <group group_id="E2">
          <title>Dose Cohort 6 (10 mL)</title>
          <description>Supraclavicular block performed with 10 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
        </group>
        <group group_id="E3">
          <title>Dose Cohort 5 (15 mL)</title>
          <description>Supraclavicular block performed with 15 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
        </group>
        <group group_id="E4">
          <title>Dose Cohort 4 (20 mL)</title>
          <description>Supraclavicular block performed with 20 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
        </group>
        <group group_id="E5">
          <title>Dose Cohort 3 (25 mL)</title>
          <description>Supraclavicular block performed with 25 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
        </group>
        <group group_id="E6">
          <title>Dose Cohort 2 (30 mL)</title>
          <description>Supraclavicular block performed with 30 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
        </group>
        <group group_id="E7">
          <title>Dose Cohort 1 (35 mL)</title>
          <description>Supraclavicular block performed with 35 mL of 2:1 mixture of 1.5% mepivacaine and 0.5% bupivacaine</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The subjects enrolled in this trial were predominantly female.
The subject population studied was free from baseline respiratory disease.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Tiffany Tedore</name_or_title>
      <organization>Weill Cornell Medical College</organization>
      <phone>212-746-2725</phone>
      <email>tft9001@med.cornell.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

